title: Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes.
abstract: Hypertension (HTN) and diabetes mellitus (DM) predispose to systemic atherosclerosis with renal involvement. The prevalence of HTN and DM in cadaveric renal donors (affected donors) and the results of transplantation are unknown. We investigated these issues with national data from the US Renal Data System. A total of 4,035 transplants from affected donors were matched 1:1 with unaffected controls according to donor age and race, recipient race, and year of transplantation. Graft and patient survival were estimated. Among the 25,039 solitary renal transplantations performed between July 1, 1994, and June 30, 1997, cadaveric renal transplants from donors with HTN accounted for 15%, and donors with DM, 2%. Programs with 1-year cadaveric renal graft survival rates greater than 90% had 50% less affected donors compared with programs having 1-year cadaveric renal graft survival rates of 85% or less. Compared with donor-age-matched controls, transplants from affected donors were at minimally increased risk for primary nonfunction, delayed graft function, and acute rejection. Three-year graft survival rates were 71% in affected donor organs and 75% in controls (P = 0.001). Compared with controls, duration of HTN was an independent risk factor for graft survival (3-year graft survival rates, 75% versus 65%; relative risk = 1.36 for HTN >10 years; P < 0.001). A substantial fraction of cadaveric renal donors have preexisting HTN. Programs transplanting fewer affected donor kidneys had better than average results. Because the negative impact of donor HTN and DM on transplant outcome was of moderate degree except when the duration of donor HTN was greater than 10 years, use of affected donors should not be discouraged, but graft and patient survival analyses should account for their presence.
authors.affiliation: Departments of Medicine, Surgery, Biostatistics, and Epidemiology, University of Michigan, Ann Arbor, MI 48109-0364, USA. aojo@umich.edu
authors.forename: A O
authors.initials: AO
authors.lastname: Ojo
authors.forename: A B
authors.initials: AB
authors.lastname: Leichtman
authors.forename: J D
authors.initials: JD
authors.lastname: Punch
authors.forename: J A
authors.initials: JA
authors.lastname: Hanson
authors.forename: D M
authors.initials: DM
authors.lastname: Dickinson
authors.forename: R A
authors.initials: RA
authors.lastname: Wolfe
authors.forename: F K
authors.initials: FK
authors.lastname: Port
authors.forename: L Y
authors.initials: LY
authors.lastname: Agodoa
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002102:Cadaver; D002423:Cause of Death; D003920:Diabetes Mellitus; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D006973:Hypertension; D016030:Kidney Transplantation / Q000401:mortality; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D015996:Survival Rate; D014019:Tissue Donors; D016896:Treatment Outcome